National Children’s Study Federal Advisory Committee Member
Dr. Galson joined Amgen as Vice President of Global Regulatory Affairs in October 2010. He was Senior Vice President for Civilian Health Operations and Chief Health Scientist at Science Applications International Corporation in October 2009 through October 2010. In October 2009, he completed 23 years of government service, most recently for two years as Acting Surgeon General of the United States. Previously, he served as Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) from July 2005, where he provided leadership for the Center’s broad national and international programs in pharmaceutical regulation. Dr. Galson began his Public Health Service (PHS) career as an epidemiological investigator at the Centers for Disease Control and Prevention (CDC) after completing a residency in internal medicine at the Hospitals of the Medical College of Pennsylvania. He has held senior-level positions at the U.S. Environmental Protection Agency (EPA); the U.S. Department of Energy, where he was Chief Medical Officer; and the U.S. Department of Health and Human Services. Prior to his arrival at FDA, he was Director of the EPA’s Office of Science Coordination and Policy, Office of Prevention, Pesticides, and Toxic Substances. Dr. Galson joined the FDA in April 2001 as CDER Deputy Director.
Dr. Galson is the recipient of numerous awards, including the Surgeon General’s Medallion and three Secretary of Energy Gold Awards. Dr. Galson has been a board member of the National Board of Medical Examiners and a peer reviewer for medical journals. He holds a BS from Stony Brook University, an MD from Mt. Sinai School of Medicine, and an MPH from the Harvard School of Public Health. He is board certified in preventive medicine and public health and occupational medicine.